Abstract
BackgroundThere have been fundamental changes in the treatment of juvenile idiopathic arthritis (JIA) over the last decade, including the introduction and widespread use of biologic DMARDs. However, the utilization of...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have